loadpatents
name:-0.013473987579346
name:-0.0071070194244385
name:-0.00044512748718262
Gliesing; Sabine Patent Filings

Gliesing; Sabine

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gliesing; Sabine.The latest application filed is for "method for enlarging the particle size of crystalline microparticles of active substance".

Company Profile
0.9.12
  • Gliesing; Sabine - Jena DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method For Enlarging The Particle Size Of Crystalline Microparticles Of Active Substance
App 20160271145 - Grawe; Detlef ;   et al.
2016-09-22
Method for producing crystalline active ingredient particles
Grant 9,211,485 - Grawe , et al. December 15, 2
2015-12-15
Crystalline active ingredient microparticles, method for producing the same and use thereof in drugs
Grant 9,173,843 - Grawe , et al. November 3, 2
2015-11-03
Arrangement and method for producing high-purity crystals
Grant 9,095,783 - Grawe , et al. August 4, 2
2015-08-04
4-[17beta-methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11-beta-yl]ben- Zaldehyde (e)-oxime (asoprisnil)
App 20130165421 - GRAWE; Detlef ;   et al.
2013-06-27
Method For Producing Crystalline Active Ingredient Particles
App 20130040141 - Grawe; Detlef ;   et al.
2013-02-14
Method for preparing 4-[17.beta.-methoxy-17.alpha.-methoxymethyl-3-oxoestra-4,9-dien-11.beta.-- yl]benzaldehyde (E)-oxime (asoprisnil)
Grant 8,324,412 - Grawe , et al. December 4, 2
2012-12-04
Method For Preparing 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11-beta-yl]be- Nzaldehyde (e)-oxime (asoprisnil)
App 20110257142 - Grawe; Detlef ;   et al.
2011-10-20
Crystalline Active Ingredient Microparticles, Method For Producing The Same And Use Thereof In Drugs
App 20110144071 - Grawe; Detlef ;   et al.
2011-06-16
Arrangement And Method For Producing High-purity Crystals
App 20110065952 - Grawe; Detlef ;   et al.
2011-03-17
Method for preparing 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxestra-4,9-dien-11beta-yl]benz- aldehyde (E)-oxime (asoprisnil)
App 20090054387 - Grawe; Detlef ;   et al.
2009-02-26
Process for production of crystals of 11.mu.-benzaldoxim-estra-4,9-diene derivatives, crystals obtained thereby and pharmaceutical preparations containing them
Grant 7,192,942 - Grawe , et al. March 20, 2
2007-03-20
Process for production of steroid crystals, steroid crystals obtained thereby and pharmaceutical preparations containing them
Grant 7,148,212 - Grawe , et al. December 12, 2
2006-12-12
Process for production of crystals of 11ss-benzaldoxim-estra-4,9-diene derivatives, crystals obtained thereby and pharmaceutical preparations containing them
App 20030225050 - Grawe, Detlef ;   et al.
2003-12-04
Process for production of crystals of a medicinally effective ingredient, crystals obtained thereby and pharmaceutical preparations containing them
App 20030215516 - Grawe, Detlef ;   et al.
2003-11-20
Process for production of crystals of an adjuvant substance, crystals obtained thereby and pharmaceutical preparations containing them
App 20030215517 - Grawe, Detlef ;   et al.
2003-11-20
Process for production of steroid crystals, steroid crystals obtained thereby and pharmaceutical preparations containing them
App 20030216360 - Grawe, Detlef ;   et al.
2003-11-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed